Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Velsera Drives Momentum in 2024 with Key Platform Advancements and Strategic Growth

    Feb 21, 2025, 08:19 AM by
    Full story
  • VECTOR LABORATORIES ANNOUNCES PARTNERSHIP WITH BRITISH BIOTECH INNOVATOR ETCEMBLY

    Feb 21, 2025, 08:19 AM by
    Vector Laboratories and Etcembly announce a collaboration to accelerate recombinant antibody therapeutic development. The collaboration combines Vector’s antibody expertise with AI-driven insights from Etcembly’s award-nominated platform.
    Full story
  • ResultsCX Rises to ‘Innovator’ Status in Avasant’s CX Center Business Process Transformation RadarView™ Assessment

    Feb 20, 2025, 08:27 AM by
    Full story
  • ClearNote Health Earns Approval for Avantect® Pancreatic Cancer Test from New York State Department of Health

    Feb 20, 2025, 08:27 AM by
    ClearNote Health announced New York State has approved its Avantect Pancreatic Cancer Test. The ClearNote Health Laboratory now has its NYSDOH permit, as well as its CLIA certification and CAP accreditation.
    Full story
  • Cleveland Clinic Announces the Rollout of Ambience Healthcare’s AI Platform

    Feb 20, 2025, 08:27 AM by
    Full story
  • Eli Lilly’s CISO Andrea Abell on Safeguarding Innovation in Pharma

    Feb 20, 2025, 01:00 AM by User Not Found
    Bio-IT World| Earlier this week at the ViVE conference in Nashville, Tenn., Bio-IT World editor, Allison Proffitt, sat down with Andrea Abell, Eli Lilly’s Chief Information Security Officer (CISO), whose mission is to protect the integrity of pharmaceutical research from inception to patient delivery. Together they discussed the critical role cybersecurity plays in Lilly’s broader goal of bringing life-changing medicines to market.
    Full story
  • Illumina’s New Spatial Products

    Feb 19, 2025, 12:45 PM by User Not Found
    Bio-IT World| Today, Illumina announced a new spatial technology program of Illumina sequencers and a multimodal analysis platform. The company also announced a collaboration with the Broad Institute on spatial transcriptomics. Illumina's spatial technology delivers unbiased whole-transcriptome profiling with cellular resolution and high sensitivity.
    Full story
  • Sapio Sciences Expands Leadership Team to Drive Growth

    Feb 19, 2025, 08:58 AM by
    Sapio Sciences today announced key leadership appointments to accelerate drug discovery and redefine AI-driven lab informatics. With the appointment of Mike Hampton as Chief Commercial Officer (CCO) and the launch of a new Scientific Office, Sapio is reinforcing its commitment to scientific and customer-driven innovation.
    Full story
  • CluePoints named as Finalist in 2025 ACDM Awards

    Feb 19, 2025, 08:58 AM by
    CluePoints, provider of leading statistical and AI-driven software solutions, has been shortlisted for “Team Excellence in the Management of Clinical Data” at the 2025 ACDM Awards.
    Full story
  • AI in Healthcare: How To Assess What Works

    Feb 18, 2025, 08:22 AM by User Not Found
    Bio-IT World| At a panel discussion this week at the ViVE conference in Nashville, Tenn., researchers and physicians discussed the promise and hype of AI. Moderated by Alexander Morgan, partner at Khosla Ventures, the discussion was wide ranging and discussed the AI tools ready for use by physicians; which classes of AI are not yet delivering; and how to assess what’s right for you.
    Full story
  • Bio-IT World Venture, Innovation & Partnering Conference Returns to Boston April 3, 2025 with Expanded AI Focus

    Feb 14, 2025, 07:53 AM by
    The second annual Bio-IT World Venture, Innovation & Partnering Conference, taking place April 3 in Boston, will bring together 200+ venture capitalists, private equity professionals, bankers, government partners, and entrepreneurs who are advancing the growth of the TechBio, biotech, drug discovery and healthcare sectors.
    Full story
  • Phastar Secures SCOPE US ‘Best in Show’ Accolade for Clinical Intelligence Platform

    Feb 14, 2025, 07:53 AM by
    Phastar, a global specialist biometrics & data science contract research organization (CRO), won a Best of Show Award at Summit for Clinical Ops Executives (SCOPE) US 2025.
    Full story
  • Ultima Genomics Sequencing Platform Selected for UK Biobank Study

    Feb 14, 2025, 01:00 AM by User Not Found
    Bio-IT World| Last month, Ultima Genomics announced that their UG 100 sequencing platform was selected by UK Biobank to be used in their human proteomics study, which is anticipated to be the largest and most comprehensive proteomics study to date. The study is intended to quantify more than 5,400 protein markers across 600,000 samples, which will help researchers understand how protein levels fluctuate over time and how these changes correlate with disease progression and aging.
    Full story
  • JuliaHub Doubles Investment in Advanced Pharmaceutical Modeling Platform

    Feb 13, 2025, 08:25 AM by
    JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved CFR Part 11-compliant pharmaceutical platform.
    Full story
  • Epigenetics Alone Can Alter Cancer Susceptibility

    Feb 13, 2025, 01:00 AM by User Not Found
    Bio-IT World| Evidence is emerging that epigenetic differences prior to birth can signal the type of cancer that occurs decades later by dictating which mutated cells turn into a tumor. It is “underappreciated” that most otherwise healthy people are walking around with cancer-causing mutations that their body suppresses unless their built-in defense system mysteriously fails.
    Full story
  • Phreesia’s Sally Thayer Selected as a Top Woman Leader in Software

    Feb 12, 2025, 08:09 AM by
    Phreesia is proud to announce that Sally Thayer, Vice President of Product Management, has been named to The Software Report’s list of the Top 50 Women Leaders in Software of 2024.
    Full story
  • GitHub Advanced Security Integrates Endor Labs Software Composition Analysis for End-to-End Application Security

    Feb 12, 2025, 08:09 AM by
    Endor Labs, the leader in open source software security, announced a critical partnership with GitHub, the platform for software developers to create and share code, that makes it easier than ever for application security teams and developers to accurately identify and remediate the most serious security vulnerabilities—all without leaving GitHub.
    Full story
  • Pillar VC Expands into UK and Launches Encode, an AI for Science Fellowship

    Feb 12, 2025, 08:09 AM by
    Backed by Pillar VC and powered by the Advanced Research + Invention Agency, the Encode Fellowship will place top AI talent in leading UK research labs to accelerate scientific breakthroughs
    Full story
  • Lifebit, Psifas Partner for Israeli Genomic Medicine Initiative

    Feb 10, 2025, 01:00 AM by User Not Found
    Bio-IT World | On the heels of its announced collaboration with 23andMe, Lifebit, has announced a long-term partnership with Psifas, Israeli Genomic Medicine Initiative. This collaboration will empower groundbreaking advancements in personalized medicine by providing a secure and unified platform for clinical-genomic research across Israel’s diverse population.
    Full story
  • Qureight and Avalyn Launch Strategic Partnership in Progressive Pulmonary Fibrosis

    Feb 7, 2025, 08:24 AM by
    A clinical trial for people living with the life-threatening lung condition Progressive Pulmonary Fibrosis (PPF) is using deep learning imaging technology to evaluate a new treatment to tackle the condition for the first time.
    Full story
  • «
  • 11
  • 12
  • 13
  • 14
  • 15 (current)
  • 16
  • 17
  • 18
  • 19
  • 20
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy